Verax Biomedical, Inc.

Verax Biomedical, Inc.

Verax Biomedical, Inc.

Date Founded




Type of Company


Employees (Worldwide)

11 - 50


Medical Products & Equipment
Other Business & Consulting Services
Hospitals & Patient Services
Holding Companies
Medical Support Services

Company Description

Verax Biomedical, Inc. develops rapid tests for detecting bacterial contaminants in blood cells and tissues. The firm's first target application for its technology is to test for the presence of bacterial contaminants in platelets and bacterial contaminants in platelets and red blood cells represent the greatest lethal infectious risks in transfusion medicine today and no rapid, simple methods are presently available to effectively address this threat. Verax Biomedical was founded by Joe R. Sanders and Joe L. Straight in 1999 and is headquartered in Marlborough, MA.

Contact Data
Trying to get in touch with decision makers at Verax Biomedical, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees


Chief Executive Officer

Chief Medical Officer & Senior Vice President

Senior Vice President-Operations

Vice President-Regulatory Affairs

Vice President-Finance & Administration

Vice President of Sales

Senior Vice President-Research & Development

Quality Assurance

Board of Directors

Venture Partner at Nextgen Venture Partners LLC

Chairman & Chief Executive Officer at Rubicon Genomics, Inc.

Chief Executive Officer at Verax Biomedical, Inc.

Co-Founder at Verax Biomedical, Inc.

Paths to Verax Biomedical, Inc.
Potential Connections via
Relationship Science
Verax Biomedical, Inc.
Recent Transactions
Details Hidden

Verax Biomedical, Inc. raised money in a private placement transaction

Details Hidden

Verax Biomedical, Inc. raised money in a private placement transaction

Details Hidden

Verax Biomedical, Inc. raised money in a private placement transaction

Details Hidden

Long River Venture invests in emerging (or secondary) market companies located in the US. The firm targets companies operating in the fields of healthcare services, healthcare IT, diagnostics, medical device. They makes follow on investments and provides financing for seed and early stage capital requirements. They invests in the range of $0.5 - $1 million and invests in companies that are raising rounds of $5 million or less. They makes co-investments and also acts as a lead or co-lead investor.

Details Hidden

KB Partners focuses their investment activities primarily in the following areas: technology products and services, medical products and services, industrial technology, commercial real estate and consumer products and services.The firm places a strong emphasis on the quality and depth of the management team that will be responsible for growing a potential portfolio company. They feel that both relevant domain expertise and prior operating experience are critical factors in building a market leading enterprise. It is extremely important for them that the core nucleus of a quality team be in place prior to the firm considering an investment.KB Partners typically participates in the seed, first, or second round of institutional funding and continues to have active involvement throughout the term of the investment. They specifically target transactions in the following categories: investments in operating companies in the early stages of their development that need capital to successfully expand their markets and business, pure start-up situations where the product, the market, the technology, the concept, or the entrepreneur provides a compelling reason to invest and experienced management seeking to purchase and operate a business, or a subsidiary or division of a larger company.The firm places a predominant emphasis on the Chicago area and surrounding Midwestern and Central US markets. While they consider opportunities outside the Midwest, it is unlikely that companies outside this geographical area will make up a significant portion of their overall portfolio.

Details Hidden

Teknoinvest is an active manager which provides financing for early-stage capital requirements, and management support. The firm invests in startups operating in the communications, technology, and health services sector, and industries such as biotechnology, information technology services, data processing services, and packaged software. It targets companies located in Northern Europe and the United States with investments between NOK 5 and 50 million, and makes follow-up investments. Teknoinvest looks to take minority stake positions in its investments.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Verax Biomedical, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Verax Biomedical, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Verax Biomedical, Inc..